Insiders · Profile

Turner Kathy V

Senior Vice President at Idexx Laboratories. Filing since 18 May 2020. CIK 0001740719

Company

Date

Role

Action

Shares

Amount

Of holding

IDXX Idexx Laboratories

16 Feb 2023

Senior Vice President

Sold, plan not stated

10

$5.16K

0.1%

IDXX Idexx Laboratories

15 Feb 2023

Senior Vice President

Sold, plan not stated

1,000

$510.03K

11.9%

IDXX Idexx Laboratories

14 Feb 2023

Senior Vice President

Sold, plan not stated

2,000

$1.01M

21.3%

IDXX Idexx Laboratories

9 Feb 2023

Senior Vice President

Sold, plan not stated

1,000

$505.04K

12.6%

IDXX Idexx Laboratories

1 Dec 2022

Senior Vice President

Sold, plan not stated

3,000

$1.31M

30.2%

IDXX Idexx Laboratories

11 Nov 2022

Senior Vice President

Sold, plan not stated

8,567

$3.76M

55.3%

IDXX Idexx Laboratories

10 Nov 2022

Senior Vice President

Sold, plan not stated

5,310

$2.16M

43.4%

IDXX Idexx Laboratories

30 Aug 2021

Senior Vice President

Sold, plan not stated

2,250

$1.55M

43.9%

IDXX Idexx Laboratories

27 Aug 2021

Senior Vice President

Sold, plan not stated

276

$187.13K

8.8%

IDXX Idexx Laboratories

28 May 2021

Senior Vice President

Sold, plan not stated

2,000

$1.12M

40.9%

IDXX Idexx Laboratories

24 May 2021

Senior Vice President

Sold, plan not stated

2,900

$1.58M

37.3%

IDXX Idexx Laboratories

21 May 2021

Senior Vice President

Sold, plan not stated

1,000

$545.00K

11.4%

IDXX Idexx Laboratories

20 May 2021

Senior Vice President

Sold, plan not stated

2,000

$1.08M

18.6%

IDXX Idexx Laboratories

18 May 2020

Corporate Vice President

Sold, plan not stated

2,690

$809.69K

21.0%

14 decisions on file.